The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB),
including but not limited to those available through the PAAB Forum, the PAAB website, and any PAAB
correspondences, are specifically intended to assist individuals navigating the PAAB preclearance system.
Repurposing or reproducing this content without written consent from the PAAB Commissioner is strictly
prohibited. This prohibition includes, but is not limited to, use in machine learning or AI models.
64 - Does exhibit booth panel text generated by head offices outside of Canada require PAAB approval for International conferences and symposia held in Canada? Does an entry in an Exhibit Guide for an International conference or symposium generated by head offices outside of Canada summarizing a recent peer reviewed published clinical trial require PAAB approval?
FYI post-approval change/preclearance exemption/what requires review/PAAB scope
1
Posts
1
Posters
577
Views
1
Watching
-
Health Canada has a policy regarding materials presented at International Conferences and can be found in the document "The Distinction Between Advertising and Other Activities" at http://www.hc-sc.gc.ca/dhp-mps/advert-publicit/pol/actv_promo_vs_info_e.html#International. To your question, based on the policy, the materials emanating from the parent company would not require PAAB review provided that they are only used within the confines of the conference and are prominently identified as not being authorized for sale in Canada.
